References
- Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet. 2005;365:1415–1428.
- Meguro S, Hasumura T, Hase T. Body fat accumulation in zebrafish is induced by a diet rich in fat and reduced by supplementation with green tea extract. PLoS One. 2015;10:e0120142.
- World Health Organization [Internet]. Obesity and overweight. Fact sheet N311 [cited 2017 Jan 17]. Available from: http://www.who.int/mediacentre/factsheets/fs311/en/
- Hariri N, Thibault L. High-fat diet-induced obesity in animal models. Nutr Res Rev. 2010;23:270–299.
- Warwick ZS, Schiffman SS. Role of dietary fat in calorie intake and weight gain. Neurosci Biobehav Rev. 1992;16:585–596.
- Tschöp M, Heiman ML. Rodent obesity models: an overview. Exp Clin Endocrinol Diabetes. 2001;109:307–319.
- Buettner R, Schölmerich J, Bollheimer LC. High-fat diets: modeling the metabolic disorders of human obesity in rodents. Obesity (Silver Spring). 2007;15:798–808.
- Boozer CN, Schoenbach G, Atkinson RL. Dietary fat and adiposity: a dose–response relationship in adult male rats fed isocalorically. Am J Physiol. 1995;268:E546–550.
- Ghibaudi L, Cook J, Farley C. Fat intake affects adiposity, comorbidity factors, and energy metabolism of Sprague-Dawley rats. Obes Res. 2002;10:956–963.
- Bourgeois F, Alexiu A, Lemonnter D. Dietary-induced obesity: effect of dietary fats on adipose tissue cellularity in mice. Br J Nutr. 1983;49:17–26.
- Takahashi M, Ikemoto S, Ezaki O. Effect of the fat/carbohydrate ratio in the diet on obesity and oral glucose tolerance in C57BL/6J mice. J Nutr Sci Vitaminol. 1999;45:583–593.
- Collins S, Martin TL, Surwit RS, et al. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol Behav. 2004;81:243–248.
- Song Y, Cone RD. Creation of a genetic model of obesity in a teleost. FASEB J. 2007;21:2042–2049.
- Amsterdam A, Hopkins N. Mutagenesis strategies in zebrafish for identifying genes involved in development and disease. Trends Genet. 2006;22:473–478.
- Lieschke GJ, Currie PD. Animal models of human disease: zebrafish swim into view. Nat Rev Genet. 2007;8:353–367.
- Hölttä-Vuori M, Salo VT, Nyberg L, et al. Zebrafish gaining popularity in lipid research. Biochem J. 2010;429:235–242.
- Anderson JL, Carten JD, Farber SA. Zebrafish lipid metabolism: from mediating early patterning to the metabolism of dietary fat and cholesterol. Methods Cell Biol. 2011;101:111–114.
- Udvadia AJ, Linney E. Windows into development: historic, current, and future perspectives on transgenic zebrafish. Dev Biol. 2003;256:1–17.
- Chu CY, Chen CF, Rajendran RS, et al. Overexpression of Akt1 enhances adipogenesis and leads to lipoma formation in zebrafish. PLoS One. 2012;7:e36474.
- Oka T, Nishimura Y, Zang L, et al. Diet-induced obesity in zebrafish shares common pathophysiological pathways with mammalian obesity. BMC Physiol. 2010;10:21.
- Hasumura T, Shimada Y, Kuroyanagi J, et al. Green tea extract suppresses adiposity and affects the expression of lipid metabolism genes in diet-induced obese zebrafish. Nutr Metab (Lond). 2012;9:73.
- Sun Z, Amsterdam A, Pazour GJ, et al. A genetic screen in zebrafish identifies cilia genes as a principal cause of cystic kidney. Development. 2004;131:4085–4093.
- Bahador R, Rinner O, Schonthaler HB, et al. The zebrafish fade out mutant: a novel genetic model for Hermansky–Pudlak syndrome. Invest Ophthalmol Vis Sci. 2006;47:4523–4531.
- Graham JL, Peter DC. Animal models of human disease: zebrafish swim into view. Nat Rev Gen. 2007;8:353–367.
- Sham TT, Chan CO, Wang YH, et al. A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect. Biomed Res Int. 2014;2014:1.
- Belguith-Hadriche O, Bouaziz M, Jamoussi K, et al. Comparative study on hypocholesterolemic and antioxidant activities of various extracts of fenugreek seeds. Food Chem. 2013;138:1448–1453.
- Mohammadi A, Oshaghi EA. Effect of garlic on lipid profile and expression of LXR alpha in intestine and liver of hypercholesterolemic mice. J Diabetes Metab Disord. 2014;13:20.
- Rahman S, Begum H, Rahman Z, et al. Effect of cinnamon (cinnamomum cassia) as a lipid lowering agent on hypercholesterolemic rats. J Enam Med Col. 2013;3:94–98.
- Askari F, Rashidkhani B, Hekmatdoost A. Cinnamon may have therapeutic benefits on lipid profile, liver enzymes, insulin resistance, and high-sensitivity C-reactive protein in nonalcoholic fatty liver disease patients. Nutr Res. 2014; 34:143–148.
- Soliman MM, Attia HF, El-Shazly SA, et al. Biomedical effects of cinnamon extract on obesity and diabetes relevance in wistar rats. Am J Biochem Mol Biol. 2012;2:133–145.
- Kassaee SM, Goodarzi MT, Roodbari NH, et al. The effects of cinnamomum zeylanicum on lipid profiles and histology via up-regulation of LDL receptor gene expression in hamsters fed a high cholesterol diet. Jundishapur J Nat Pharm Prod. 2017;12:e37340.
- Tuzcu Z, Orhan C, Sahin N, et al. Cinnamon polyphenol extract inhibits hyperlipidemia and inflammation by modulation of transcription factors in high-fat diet-fed rats. Oxid Med Cell Longev. 2017;2017:1.
- Cao H, Sethumadhavan K, Li K, et al. Cinnamon polyphenol extract and insulin regulate diacylglycerol acyltransferase gene expression in mouse adipocytes and macrophages. Plant Foods Hum Nutr. 2019;74:115–121.
- Cao H, Urban JF Jr, Anderson RA. Cinnamon polyphenol extract affects immune responses by regulating anti- and proinflammatory and glucose transporter gene expression in mouse macrophages. J Nutr. 2008;138:833–840.
- Turola E, Petta S, Vanni E, et al. Ovarian senescence increases liver fibrosis in humans and zebrafish with steatosis. Dis Model Mech. 2015;8:1037–1046.
- Ahmed MH, Byrne CD. Modulation of sterol regulatory element binding proteins (SREBPs) as potential treatments for non-alcoholic fatty liver disease (NAFLD). Drug Discov Today. 2007;12:740–747.
- Donnelly KL, Smith CI, Schwarzenberg SJ, et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 2005;115:1343–1351.
- Harari A, Harats D, Marko D, et al. A 9-cis beta-carotene-enriched diet inhibits atherogenesis and fatty liver formation in LDL receptor knockout mice. J Nutr. 2008;138:1923–1930.
- Ahuja KD, Pittaway JK, Ball MJ. Effects of olive oil and tomato lycopene combination on serum lycopene, lipid profile, and lipid oxidation. Nutr 2006;22:259–265.
- Wang GL, Fu YC, Xu WC, et al. Resveratrol inhibits the expression of SREBP1 in cell model of steatosis via Sirt1-FOXO1 signaling pathway. Biochem Biophys Res Commun. 2009;380:644–649.
- Fan W, Imamura T, Sonoda N, et al. FOXO1 transrepresses peroxisome proliferator-activated receptor gamma transactivation, coordinating an insulin-induced feed-forward response in adipocytes. J Biol Chem. 2009;284:12188–12197.
- Stroup D, Crestani M, Chiang JY. Orphan receptors chicken ovalbumin upstream promoter transcription factor II (COUP-TFII) and retinoid X receptor (RXR) activate and bind the rat cholesterol 7alpha-hydroxylase gene (CYP7A). J Biol Chem. 1997;272:9833–9839.
- Wang Y, Ausman LM, Greenberg AS, et al. Dietary lycopene and tomato extract supplementations inhibit nonalcoholic steatohepatitis-promoted hepatocarcinogenesis in rats. Int J Cancer. 2010;126:1788–1796.
- Chen H, Zhang H, Lee J, et al. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res. 2007;67:8007–8013.
- Raman V, Martensen SA, Reisman D, et al. Compromised HOXA5 function can limit p53 expression in human breast tumours. Nature. 2000;405:974–978.
- Baumer W, Hoppmann J, Rundfeldt C, et al. Highly selective phosphodiesterase 4 inhibitors for the treatment of allergic skin diseases and psoriasis. IADT. 2007;6:17–26.
- Souness JE, Aldous D, Sargent C. Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology. 2000;47:127–162.
- Wang P, Ohleth KM, Wu P, et al. Phosphodiesterase 4B2 is the predominant phosphodiesterase species and undergoes differential regulation of gene expression in human monocytes and neutrophils. Mol Pharmacol. 1999;56:170–174.
- Kim SH, Hyun SH, Choung SY. Anti-diabetic effect of cinnamon extract on blood glucose in db/db mice. J Ethnopharmacol. 2006;104:119–123.
- Kannappan S, Jayaraman T, Rajasekar P, et al. Cinnamon bark extract improves glucose metabolism and lipid profile in the fructose-fed rat. Singapore Med J. 2006;47:858–863.
- Lu T, Sheng H, Wu J, et al. Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutr Res. 2012;32:408–412.
- O'Keefe JH, Gheewala NM, O'Keefe JO. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol. 2008;51:249–255.
- Magistrelli A, Chezem JC. Effect of ground cinnamon on postprandial blood glucose concentration in normal-weight and obese adults. J Acad Nutr Diet. 2012;112:1806–1809.
- Kim W, Khil LY, Clark R, et al. Naphthalenemethyl ester derivative of dihydroxyhydrocinnamic acid, a component of cinnamon, increases glucose disposal by enhancing translocation of glucose transporter 4. Diabetologia. 2006;49:2437–2448.
- Qin B, Panickar KS, Anderson RA. Cinnamon: potential role in the prevention of insulin resistance, metabolic syndrome, and type 2 diabetes. J Diabetes Sci Technol. 2010;4:685–693.
- Li R, Liang T, Xu L, et al. Protective effect of cinnamon polyphenols against STZ-diabetic mice fed high-sugar, high-fat diet and its underlying mechanism. Food Chem Toxicol. 2013;51:419–425.